Sector › Medicine
Press Releases
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders
PCG Digital
Jun 13, 2023 21:00 HKT/SGT
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
China Medical System Holdings Ltd.
Jun 12, 2023 21:00 JST
中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎（AD）的新药研究申请获国家药监局药品审评中心受理
SinoMab BioScience Limited
Jun 12, 2023 20:45 HKT/SGT
中國抗體SM17再增一項適應症研究申請 針對治療特應性皮炎（AD）的新藥研究申請獲國家藥監局藥品審評中心受理
SinoMab BioScience Limited
Jun 12, 2023 20:44 HKT/SGT
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE
SinoMab BioScience Limited
Jun 12, 2023 20:43 HKT/SGT
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
China Medical System Holdings Ltd.
Jun 12, 2023 20:00 HKT/SGT
國際助產士聯合會在巴厘島舉行的第 33 屆三年一度的大會上接待了數千名代表
International Confederation of Midwives
Jun 09, 2023 13:00 HKT/SGT
国际助产士联合会在巴厘岛举行的第 33 届三年一度的大会上接待了数千名代表
International Confederation of Midwives
Jun 09, 2023 13:00 HKT/SGT
Pilot Project for Lifelog-based Health Services in Muraoka-Fukasawa District
Mitsubishi Corporation
Jun 09, 2023 10:47 HKT/SGT
International Confederation of Midwives to Host Thousands of Delegates at Its 33rd Triennial Congress in Bali
International Confederation of Midwives
Jun 08, 2023 23:00 HKT/SGT
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO
Sihuan Pharmaceutical Holdings Group Ltd.
Jun 08, 2023 21:18 HKT/SGT
四环医药旗下轩竹生物创新研发全速前进 携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相
Sihuan Pharmaceutical Holdings Group Ltd.
Jun 08, 2023 21:16 HKT/SGT
四環醫藥旗下軒竹生物創新研發全速前進 攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相
Sihuan Pharmaceutical Holdings Group Ltd.
Jun 08, 2023 21:15 HKT/SGT
Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea
Eisai
Jun 08, 2023 12:32 HKT/SGT
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease
Coya Therapeutics, Inc.
Jun 08, 2023 06:26 HKT/SGT
